Development of a stable ERroGFP variant suitable for monitoring redox dynamics in the ER

por Hoseki, Jun, Oishi, Asami, Fujimura, Takaaki, Sakai, Yasuyoshi
Publicado 2016

Homeostasis of the ER redox state subsequent to proteasome inhibition

por Oku, Yuki, Kariya, Masahiro, Fujimura, Takaaki, Hoseki, Jun, Sakai, Yasuyoshi
Publicado 2021

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes

por Furugaki, Koh, Fujimura, Takaaki, Mizuta, Hayato, Yoshimoto, Takuya, Asakawa, Takashi, Yoshimura, Yasushi, Yoshiura, Shigeki
Publicado 2023

Combination efficacy of pertuzumab and trastuzumab for trastuzumab emtansine-resistant cells exhibiting attenuated lysosomal trafficking or efflux pumps upregulation

por Yamashita-Kashima, Yoriko, Shu, Sei, Osada, Masahiro, Fujimura, Takaaki, Yoshiura, Shigeki, Harada, Naoki, Yoshimura, Yasushi
Publicado 2020

Resistance to obinutuzumab-induced antibody-dependent cellular cytotoxicity caused by abnormal Fas signaling is overcome by combination therapies

por Kawasaki, Natsumi, Yamashita-Kashima, Yoriko, Fujimura, Takaaki, Yoshiura, Shigeki, Harada, Naoki, Kondoh, Osamu, Yoshimura, Yasushi
Publicado 2022